Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram/copper-induced oxidative stress and ferroptosis in renal cell carcinoma-Reference-Cited by-同舟云学术

Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram/copper-induced oxidative stress and ferroptosis in renal cell carcinoma

Published:2023-12 Issue: Volume:960 Page:176110
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ni Xinmiao,Ye Chenglin,Yu Xi,Zhang Ye,Hou Yanguang,Zheng Qingyuan,Chen Zhiyuan,Wang Lei,Weng Xiaodong,Yang Chuan,Liu Xiuheng

Funder

National Natural Science Foundation of China

Guangxi Key Research and Development Program

Publisher

Elsevier BV

Subject

Pharmacology

Reference52 articles.

1. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer;Allensworth;Mol. Oncol.,2015

2. Toward an understanding of the Cdc48/p97 ATPase;Bodnar;F1000Res,2017

3. iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4;Chen;Nat. Commun.,2021

4. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity;Chen;Cancer Res.,2006

5. Prospects for anti-tumor mechanism and potential clinical application based on glutathione peroxidase 4 mediated ferroptosis;Chen;Int. J. Mol. Sci.,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of deubiquitylating enzyme USP21 as a potential therapeutic target in cancer;Bioorganic Chemistry;2024-06

2. Targeting cuproplasia and cuproptosis in cancer;Nature Reviews Clinical Oncology;2024-03-14